SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Class A | - | - | - | - | - | - | - | 0 | - | - | - | 4 | |||||
Common Class B | - | - | - | - | - | - | - | 0 | - | - | - | 0 | |||||
Assets | |||||||||||||||||
Cash | - | - | - | - | - | - | - | - | 2 | 0 | 1 | 1 | |||||
Cash And Cash Equivalents At Carrying Value | 167 | 164 | 127 | 153 | 132 | 125 | 137 | 1 | - | 103 | - | 1 | |||||
Inventory Net | 2 | 3 | 2 | 2 | 2 | 1 | 2 | - | - | 3 | - | - | |||||
Short Term Investments | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 239 | 231 | 227 | 241 | 215 | 184 | 202 | 1 | 2 | 166 | 1 | 1 | |||||
Direct Financing Lease Net Investment In Lease Aft… | 13 | 13 | 10 | 9 | 7 | 6 | 8 | - | - | 6 | - | - | |||||
Contract With Customer Receivable After Allowance … | 7 | 9 | 12 | 11 | 9 | 10 | 16 | - | - | 8 | - | - | |||||
Prepaid Expense And Other Assets Current | 11 | 12 | 15 | 14 | 33 | 11 | 8 | 0 | 0 | 10 | 0 | 0 | |||||
Income Tax Receivable | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Assets Held In Trust Noncurrent | - | - | - | - | - | - | - | 18 | 18 | 21 | 21 | 20 | |||||
Accrued Liabilities Current | - | - | - | - | - | - | - | 1 | 1 | 0 | 0 | 0 | |||||
Short Term Borrowings | - | - | - | - | - | - | - | - | 3 | - | - | - | |||||
Property Plant And Equipment Net | 7 | 8 | 7 | 8 | 9 | 9 | 13 | - | - | 14 | - | - | |||||
Convertible Debt Current | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | |||||
Long Term Investments | 1 | - | - | - | - | 3 | 5 | - | - | 1 | - | - | |||||
Intangible Assets Net Excluding Goodwill | 47 | 48 | 23 | 2 | 2 | 2 | 16 | - | - | 20 | - | - | |||||
Marketable Securities Noncurrent | 1 | - | - | - | - | - | - | - | - | - | - | - | |||||
Equity Method Investments | 20 | 20 | - | - | - | 0 | - | - | - | - | - | - | |||||
Assets Noncurrent | |||||||||||||||||
Assets Noncurrent | 149 | 149 | 94 | 74 | 70 | 82 | 94 | - | - | 93 | - | - | |||||
Goodwill | 15 | 15 | 5 | 5 | 5 | 5 | 4 | - | - | 4 | - | - | |||||
Crypto Asset Fair Value Noncurrent | - | - | 1 | 1 | - | - | - | - | - | - | - | - | |||||
Direct Financing Lease Net Investment In Lease Aft… | 13 | 14 | 15 | 13 | 11 | 8 | 5 | - | - | 3 | - | - | |||||
Operating Lease Right Of Use Asset | 11 | 8 | 5 | 5 | 5 | 5 | 5 | - | - | 6 | - | - | |||||
Finance Lease Right Of Use Asset | 0 | 0 | 0 | 1 | 1 | 0 | - | - | - | - | - | - | |||||
Deferred Income Tax Assets Net | 5 | 4 | 1 | 2 | 3 | 10 | 1 | - | - | - | - | - | |||||
Contract With Customer Receivable After Allowance … | 3 | 5 | 7 | 6 | 5 | 5 | 7 | - | - | 6 | - | - | |||||
Prepaid Expense Noncurrent | 1 | 0 | 0 | 2 | 2 | 2 | 4 | - | - | 4 | - | - | |||||
Other Assets Noncurrent | 7 | 7 | 7 | 7 | 7 | 16 | 16 | - | - | 15 | - | - | |||||
Assets | 388 | 380 | 321 | 315 | 285 | 266 | 296 | 20 | 20 | 259 | 21 | 22 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | - | - | - | - | - | - | 15 | 0 | 0 | 0 | 0 | 0 | |||||
Loans Payable Current | 9 | 9 | 3 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Notes Payable Current | - | 0 | 2 | 3 | 1 | 0 | 10 | 3 | - | 3 | - | - | |||||
Accrued Income Taxes Current | 8 | 9 | 1 | 14 | 2 | 19 | 8 | 0 | 0 | 9 | - | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 63 | 61 | 45 | 61 | 48 | 61 | 72 | 4 | 4 | 92 | 2 | 2 | |||||
Sales And Excise Tax Payable Current | - | - | - | - | - | - | - | 1 | 1 | 1 | - | - | |||||
Operating Lease Liability Current | 6 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | 4 | - | - | |||||
Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Other Accrued Liabilities Current | 12 | 12 | 5 | 6 | 9 | 8 | 12 | - | - | 21 | - | - | |||||
Deferred Compensation Liability Classified Noncurr… | - | - | - | - | - | - | - | 4 | 4 | 4 | 4 | 4 | |||||
Deferred Income Tax Liabilities | - | - | - | - | - | - | 4 | - | - | - | - | - | |||||
Long Term Loans Payable | 31 | 34 | 18 | 7 | 7 | 7 | 1 | - | - | 1 | - | - | |||||
Long Term Notes Payable | - | 0 | 0 | - | 0 | 0 | 12 | - | - | 12 | - | - | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities Noncurrent | 55 | 56 | 29 | 10 | 10 | 10 | 19 | - | - | 23 | - | - | |||||
Operating Lease Liability Noncurrent | 6 | 4 | 2 | 1 | 1 | 1 | 2 | - | - | 2 | - | - | |||||
Stock Issued During Period Shares Conversion Of Co… | - | - | - | - | - | - | - | - | - | 3 | - | - | |||||
Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 2 | 2 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | - | |||||
Liabilities | 118 | 117 | 73 | 71 | 58 | 71 | 91 | 9 | 8 | 115 | 6 | 7 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | 2 | - | 21 | 21 | 20 | |||||
Stockholders Equity Defic… | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Additional Paid In Capital | 73 | 73 | 72 | 72 | 63 | 63 | 8 | 15 | 15 | 37 | - | - | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 255 | 263 | 248 | 245 | 226 | 195 | 206 | 161 | 151 | 142 | -6 | -5 | |||||
Treasury Stock Value | -8 | -8 | -8 | -5 | -3 | -3 | -3 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | 252 | 240 | 226 | 213 | 211 | 189 | 183 | -7 | -6 | 143 | -6 | -5 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -62 | -57 | -43 | -36 | -44 | -54 | -36 | - | - | -38 | - | - | |||||
Minority Interest | 15 | 15 | 0 | 0 | -0 | -0 | 1 | - | - | 2 | - | - | |||||
Liabilities And Stockholders Equity | 388 | 380 | 321 | 315 | 285 | 266 | 296 | 20 | 20 | 259 | 21 | 22 | |||||
Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Temporary Equity Redemption Price Per Share | - | - | - | - | - | - | - | 11.59 | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 1 | 1 | 20 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | - | - | 400 | - | - | |||||
Common Stock Shares Issued | 104 | 104 | 104 | 104 | 104 | 103 | 103 | - | - | 94 | - | - | |||||
Shares Outstanding | 103 | 103 | 103 | 103 | 104 | 103 | 103 | - | - | 94 | - | - | |||||
Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 0 | 0 | 0 | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.01% | 9.06% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 35.63% | 28.45% | 20.11% | -3.82% | -1.97% | -24.45% | 13.29% | 30.82% | 38.37% | 13.38% | -25.00% | -27.53% |
| 2024 | 5.84% | 0.92% | 6.76% | -35.79% | -43.86% | -51.86% | -11.35% | -19.25% | -29.60% | 22.56% | 3.66% | 35.06% |
| 2023 | 1.08% | 2.76% | 3.21% | 0.67% | 1.81% | 1.62% | 0.75% | 0.94% | 2.82% | -6.88% | 4.00% | 4.88% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.82 | 3.78 | 5.10 | 3.98 | 4.44 | 3.01 | 2.79 | 0.32 | 0.40 | 1.79 | 0.30 | 0.46 | |||||
| Quick Ratio | 3.60 | 3.55 | 4.73 | 3.72 | 3.72 | 2.81 | 2.65 | 0.31 | 0.38 | 1.65 | 0.24 | 0.39 | |||||
| Working Capital | 176.21M | 170.10M | 182.62M | 180.66M | 166.63M | 123.26M | 129.68M | -3.04M | -2.63M | 73.45M | -1.70M | -1.33M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.44 | 0.44 | 0.30 | 0.29 | 0.26 | 0.36 | 0.44 | 0.96 | 0.93 | -19.18 | 0.05 | -1.25 | |||||
| Interest Coverage TTM | 226.63 | 420.26 | 507.76 | 777.32 | 2,223.72 | 2,484.23 | 2,046.51 | 2,212.21 | 1,977.42 | 1,560.10 | 4,756.90 | - | |||||
| Debt Ratio | 0.30 | 0.31 | 0.23 | 0.22 | 0.20 | 0.27 | 0.31 | 0.44 | 0.43 | 0.44 | 0.30 | 0.30 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.50 | 0.54 | 0.58 | 1.12 | 1.30 | 0.78 | 1.93 | 14.66 | 3.53 | 1.02 | 0.67 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.40 | 0.50 | 0.42 | 0.32 | 0.48 | 0.48 | 0.74 | 0.80 | 0.61 | 0.42 | 0.10 | 0.01 | |||||
| Free Cash Flow Per Share TTM | 0.30 | 0.23 | -0.35 | -0.10 | 0.16 | 0.19 | 0.49 | 0.69 | 0.48 | 0.45 | 0.23 | -0.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.80% | 73.32% | 74.09% | 76.97% | 77.94% | 75.97% | 73.55% | 71.73% | - | - | - | - | |||||
| Operating Profit Margin TTM | 36.02% | 38.87% | 33.26% | 30.45% | 35.39% | 34.23% | 38.11% | 40.89% | 38.46% | 36.51% | 40.02% | - | |||||
| Net Profit Margin TTM | 24.12% | 29.40% | 24.33% | 17.76% | 24.98% | 22.73% | 22.87% | 25.14% | 23.16% | 20.34% | 20.59% | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -14.45% | -15.48% | -41.92% | -37.57% | -20.30% | 6.13% | 549.89% | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -17.38% | 9.33% | -38.22% | -55.91% | -14.02% | 18.59% | 622.05% | 5,454.54% | 4,831.37% | - | - | - | |||||
| EPS Growth (1Y) | -16.81% | 2.50% | -42.76% | -59.88% | -21.59% | 15.68% | 615.19% | 5,765.19% | 7,559.54% | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 10.50 | 8.70 | 10.26 | 14.37 | 6.66 | 11.50 | 10.79 | 16.24 | 20.80 | 25.77 | 103.32 | 750.02 | |||||
| P/B TTM | 1.59 | 1.69 | 1.80 | 1.96 | 1.46 | 2.75 | 3.69 | 139.41 | 132.65 | -169.22 | 8.20 | -196.58 | |||||
| P/S TTM | 2.53 | 2.56 | 2.50 | 2.55 | 1.66 | 2.61 | 2.47 | 4.08 | 4.82 | 5.24 | 21.27 | - | |||||
| Market Cap | 428.77M | 443.92M | 445.47M | 480.27M | 329.45M | 536.88M | 757.91M | 1.23B | 1.20B | 1.01B | 1.01B | 1.02B | |||||
| Enterprise Value | 270.67M | 289.50M | 323.00M | 331.20M | 199.25M | 411.96M | 642.51M | 1.23B | 1.20B | 927.90M | 1.01B | 1.02B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 30.70M | 23.27M | -35.79M | -10.26M | 16.71M | 18.02M | 46.66M | 64.75M | 45.50M | 42.13M | 21.28M | -1.77M | |||||
| Net Debt | -158.11M | -154.43M | -122.47M | -149.07M | -130.20M | -124.92M | -115.40M | 1.32M | 1.04M | -86.55M | 425.66K | 25.08K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SBC Medical Group Holdings Inc (SBC) — SEC Financial Statements & Analysis
SBC Medical Group Holdings Inc (SBC) is a services-offices & clinics of doctors of medicine company, incorporated in DE. SBC Medical Group Holdings Inc trades on SBCWW: Nasdaq as: SBC: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), SBC Medical Group Holdings Inc reported a -14.45% year-over-year revenue growth, a Gross Profit Margin of 70.80% (TTM), a Debt-to-Equity ratio of 0.44x, a Price-to-Sales (P/S) ratio of 2.53x (TTM), a Price-to-Book (P/B) ratio of 1.59 (TTM), at a market cap of $428.77M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -14.45%
- Gross Profit Margin TTM
- 70.80%
- Debt To Equity
- 0.44x
- P/S TTM
- 2.53x
- P/B TTM
- 1.59
- Market Cap
- $428.77M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SBC Medical Group Holdings Inc in?
SBC Medical Group Holdings Inc (SBC) operates in the Services-Offices & Clinics of Doctors of Medicine industry.
What is SBC's market cap?
SBC Medical Group Holdings Inc (SBC) has a market capitalization of $428.77M as of 2026-03-31.
What is SBC's P/E ratio?
SBC Medical Group Holdings Inc (SBC)'s trailing twelve month P/E ratio is 10.50x as of 2026-03-31.
What exchange does SBC trade on?
SBC Medical Group Holdings Inc (SBC) trades on the SBCWW: Nasdaq.
Where is SBC Medical Group Holdings Inc incorporated?
SBC Medical Group Holdings Inc is incorporated in DE.